Indole Cytosolic Phospholipase A2α Inhibitors: Discovery and in Vitro and in Vivo Characterization of 4-{3-[5-Chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic Acid, Efipladib
Authors:
- 23 May 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (12) , 3388-3413
Abstract
The optimization of a class of indole cPLA2α inhibitors is described herein. The importance of the substituent at C3 and the substitution pattern of the phenylmethane sulfonamide region are highlighted. Optimization of these regions led to the discovery of 111 (efipladib) and 121 (WAY-196025), which are shown to be potent, selective inhibitors of cPLA2α in a variety of isolated enzyme assays, cell based assays, and rat and human whole blood assays. The binding of these compounds has been further examined using isothermal titration calorimetry. Finally, these compounds have shown efficacy when dosed orally in multiple acute and chronic prostaglandin and leukotriene dependent in vivo models.Keywords
This publication has 69 references indexed in Scilit:
- Differential effect of zileuton, a 5-lipoxygenase inhibitor, against nociceptive paradigms in mice and ratsPharmacology Biochemistry and Behavior, 2005
- Cytosolic Phospholipase A2α–deficient Mice Are Resistant to Collagen-induced ArthritisJournal of Experimental Medicine, 2003
- Roles for cytosolic phospholipase A2α as revealed by gene-targeted miceProstaglandins & Other Lipid Mediators, 2002
- A β-Lactam Inhibitor of Cytosolic Phospholipase A2which Acts in a Competitive, Reversible Manner at the Lipid/Water InterfaceJournal of Enzyme Inhibition, 1998
- Structure-activity relationship studies on (4-acylpyrrol-2-yl)alkanoic acids as inhibitors of the cytosolic phospholipase A2: Variation of the alkanoic acid substituent, the acyl chain and the position of the pyrrole nitrogenEuropean Journal of Medicinal Chemistry, 1997
- Structure−Activity Relationships of (4-Acylpyrrol-2-yl)alkanoic Acids as Inhibitors of the Cytosolic Phospholipase A2: Variation of the Substituents in Positions 1, 3, and 5Journal of Medicinal Chemistry, 1997
- Irreversible inhibition of Ca2+-independent phospholipase A2 by methyl arachidonyl fluorophosphonateBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- 3‐(Octadecanoylaminomethyl)indole‐2‐carboxylic Acid Derivatives and 1‐Methyl‐3‐octadecanoylindole‐2‐carboxylic Acid as Inhibitors of Cytosolic Phospholipase A2Archiv der Pharmazie, 1996
- Erratum: Pharmacology of montelukast sodium (Singulair™), a potent and selective leukotriene D4 receptor antagonistCanadian Journal of Physiology and Pharmacology, 1995
- Role of Arachidonic Acid Metabolites in Allergen-Induced Late ResponsesRespiration, 1989